Quick medicine delivery startup Plazza, founded by former Zomato head of dining out Aman Priyadarshi, has raised $1.4 million in a funding round led by All In Capital. Other participants include Better Capital, Tracxn founder Abhishek Goyal, Bounce’s founder Vivekananda Hallekere, the Singhania family office, and the promoters of JK Tyre.
The medicine delivery company plans to utilize the funds to expand its product range and increase its store presence in Bengaluru. Currently, Plazza operates one store in the city, but it will soon add two more this year. Furthermore, with a delivery window of just 15 to 60 minutes, the startup has adopted an omnichannel strategy. Notably, it began operations with its flagship outlet in Yemalur and, moving forward, it intends to open 20 additional stores over the next 12 months.
“A typical pharmacy has 4,000-5,000 SKUs (stock keeping units), which is very small and doesn’t have all the medicines that customers need,’’ said Priyadarshi, founder and chief executive. “We are challenging how pharma is retailed. We have 20,000 SKUs which can be directly purchased from our store or delivered.’’
Plazza also plans to diversify its offerings to include healthy snacks, mother and baby care, elder care, and dermatology products across both its app and physical stores. “So far, we have served 10,000 customers and the business is growing 25% weekly of late,’’ Priyadarshi added.
Priyadarshi and Aniruddha Sen, cofounder of Kenko Health, launched the startup in November 2024 after Kenko Health shut down in August last year due to a funding shortfall.
The funding round comes amid rising competition in quick commerce, as platforms race to provide faster access to medicines and supplements. For instance, Instamart has partnered with Pharmeasy, while Zepto is simultaneously pursuing an independent strategy. Moreover, Amazon has teamed up with Orange Health to expand its diagnostic services.
Earlier this month, Bengaluru-based online pharmacy PlatinumRx secured $6 million in funding from Stellaris Venture Partners, while in August, Truemeds raised $85 million in a round led by Accel and Peak XV Partners.
